Evolving epidemiology of hepatitis C virus
- PMID: 21091831
- DOI: 10.1111/j.1469-0691.2010.03432.x
Evolving epidemiology of hepatitis C virus
Abstract
More than 20 years after the discovery of the hepatitis C virus (HCV), it is now well established that HCV is of global importance affecting all countries, leading to a major global health problem that requires widespread active interventions for its prevention and control. Chronic hepatitis C was linked to the development of cirrhosis and hepatocellular carcinoma in many areas of the world. Current epidemiological assessments have identified complex patterns with highly variable local prevalence rates between countries and within countries. HCV infection patterns have not significantly changed in most parts of the world since 1997, when first analyzed, partly due to the lack of new and more accurate data. The assessment of the national HCV prevalence and transmission modes should be completed to enable national authorities to prioritize preventive measures and to make the most appropriate use of available resources. The 'patchy' epidemiological situation in some areas will continue to complicate the task of the establishment of global, regional and national base line data. The present assessment finds a global prevalence of 2.35%, affecting 160 million chronically infected individuals. There is an urgent need for more accurate Information on the costs and burden of HCV to society. Twenty-one year after the discovery of HCV, the assessment is far from being complete and little progress has been made in the past 10 years in many countries. In some countries significant increases have been reported and this may also apply to countries were insufficient data exist. A safe and efficient vaccine against HCV is urgently needed.
© 2011 The Author. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.
Similar articles
-
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.Oncogene. 2006 Jun 26;25(27):3771-7. doi: 10.1038/sj.onc.1209560. Oncogene. 2006. PMID: 16799618 Review.
-
Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.J Gastroenterol Hepatol. 2000 Nov;15(11):1282-6. J Gastroenterol Hepatol. 2000. PMID: 11129222
-
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.J Med Virol. 2005 Apr;75(4):522-7. doi: 10.1002/jmv.20313. J Med Virol. 2005. PMID: 15714480
-
Epidemiology and prevention of hepatocellular carcinoma.Cancer Lett. 2009 Dec 1;286(1):5-8. doi: 10.1016/j.canlet.2008.10.046. Epub 2008 Dec 12. Cancer Lett. 2009. PMID: 19070421 Review.
-
High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposure.Panminerva Med. 2003 Dec;45(4):253-9. Panminerva Med. 2003. PMID: 15206166
Cited by
-
Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study.BMC Infect Dis. 2014 Dec 21;14:716. doi: 10.1186/s12879-014-0716-8. BMC Infect Dis. 2014. PMID: 25528575 Free PMC article.
-
Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.J Int AIDS Soc. 2015 May 22;18(1):19888. doi: 10.7448/IAS.18.1.19888. eCollection 2015. J Int AIDS Soc. 2015. PMID: 26004637 Free PMC article.
-
The application and mechanism of action of ribavirin in therapy of hepatitis C.Antivir Chem Chemother. 2012 Sep 25;23(1):1-12. doi: 10.3851/IMP2125. Antivir Chem Chemother. 2012. PMID: 22592135 Free PMC article. Review.
-
Structural analysis of hepatitis C virus core-E1 signal peptide and requirements for cleavage of the genotype 3a signal sequence by signal peptide peptidase.J Virol. 2012 Aug;86(15):7818-28. doi: 10.1128/JVI.00457-12. Epub 2012 May 16. J Virol. 2012. PMID: 22593157 Free PMC article.
-
Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.Hepatol Int. 2015 Oct;9(4):486-507. doi: 10.1007/s12072-015-9630-4. Epub 2015 May 5. Hepatol Int. 2015. PMID: 25941137 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous